Selected research
Industry Research
Fibrin Sealant (Human) Industry Research Report 2026
Market perspective
The global Fibrin Sealant (Human) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Fibrin Sealant (Human) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Fibrin Sealant (Human) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Fibrin Sealant (Human) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Fibrin Sealant (Human) include Behringwerke, CSL, Grifols, Immuno, Octapharma, Baxter, Bayer, Hualan Biological and Shanghai RAAS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Fibrin Sealant (Human) market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fibrin Sealant (Human) Market by Company
Behringwerke
CSL
Grifols
Immuno
Octapharma
Baxter
Bayer
Hualan Biological
Shanghai RAAS
Fibrin Sealant (Human) Segment by Type
2mL/Set
4mL/Set
10mL/Set
Fibrin Sealant (Human) Segment by Application
Hospital
Clinic
Other
Fibrin Sealant (Human) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibrin Sealant (Human) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fibrin Sealant (Human) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibrin Sealant (Human).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fibrin Sealant (Human) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fibrin Sealant (Human) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fibrin Sealant (Human) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2mL/Set
- 4mL/Set
- 10mL/Set
Applications
- Hospital
- Clinic
- Other
Companies covered
- Behringwerke
- CSL
- Grifols
- Immuno
- Octapharma
- Baxter
- Bayer
- Hualan Biological
- Shanghai RAAS
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fibrin Sealant (Human) Market Size (2021-2032)
- 2.2.2 Global Fibrin Sealant (Human) Sales (2021-2032)
- 2.2.3 Global Fibrin Sealant (Human) Market Average Price (2021-2032)
- 2.3 Fibrin Sealant (Human) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 2mL/Set
- 2.3.3 4mL/Set
- 2.3.4 10mL/Set
- 2.4 Fibrin Sealant (Human) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fibrin Sealant (Human) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fibrin Sealant (Human) Sales (K Tons) of Manufacturers (2021-2026)
- 3.3 Global Fibrin Sealant (Human) Revenue of Manufacturers (2021-2026)
- 3.4 Global Fibrin Sealant (Human) Average Price by Manufacturers (2021-2026)
- 3.5 Global Fibrin Sealant (Human) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fibrin Sealant (Human), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fibrin Sealant (Human), Product Type & Application
- 3.8 Global Manufacturers of Fibrin Sealant (Human), Established Date
- 3.9 Global Fibrin Sealant (Human) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Behringwerke
- 4.1.1 Behringwerke Company Information
- 4.1.2 Behringwerke Business Overview
- 4.1.3 Behringwerke Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Behringwerke Fibrin Sealant (Human) Product Portfolio
- 4.1.5 Behringwerke Recent Developments
- 4.2 CSL
- 4.2.1 CSL Company Information
- 4.2.2 CSL Business Overview
- 4.2.3 CSL Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CSL Fibrin Sealant (Human) Product Portfolio
- 4.2.5 CSL Recent Developments
- 4.3 Grifols
- 4.3.1 Grifols Company Information
- 4.3.2 Grifols Business Overview
- 4.3.3 Grifols Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Grifols Fibrin Sealant (Human) Product Portfolio
- 4.3.5 Grifols Recent Developments
- 4.4 Immuno
- 4.4.1 Immuno Company Information
- 4.4.2 Immuno Business Overview
- 4.4.3 Immuno Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Immuno Fibrin Sealant (Human) Product Portfolio
- 4.4.5 Immuno Recent Developments
- 4.5 Octapharma
- 4.5.1 Octapharma Company Information
- 4.5.2 Octapharma Business Overview
- 4.5.3 Octapharma Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Octapharma Fibrin Sealant (Human) Product Portfolio
- 4.5.5 Octapharma Recent Developments
- 4.6 Baxter
- 4.6.1 Baxter Company Information
- 4.6.2 Baxter Business Overview
- 4.6.3 Baxter Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Baxter Fibrin Sealant (Human) Product Portfolio
- 4.6.5 Baxter Recent Developments
- 4.7 Bayer
- 4.7.1 Bayer Company Information
- 4.7.2 Bayer Business Overview
- 4.7.3 Bayer Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer Fibrin Sealant (Human) Product Portfolio
- 4.7.5 Bayer Recent Developments
- 4.8 Hualan Biological
- 4.8.1 Hualan Biological Company Information
- 4.8.2 Hualan Biological Business Overview
- 4.8.3 Hualan Biological Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hualan Biological Fibrin Sealant (Human) Product Portfolio
- 4.8.5 Hualan Biological Recent Developments
- 4.9 Shanghai RAAS
- 4.9.1 Shanghai RAAS Company Information
- 4.9.2 Shanghai RAAS Business Overview
- 4.9.3 Shanghai RAAS Fibrin Sealant (Human) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shanghai RAAS Fibrin Sealant (Human) Product Portfolio
- 4.9.5 Shanghai RAAS Recent Developments
5 Global Fibrin Sealant (Human) Market Scenario by Region
- 5.1 Global Fibrin Sealant (Human) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fibrin Sealant (Human) Sales by Region: 2021-2032
- 5.2.1 Global Fibrin Sealant (Human) Sales by Region: 2021-2026
- 5.2.2 Global Fibrin Sealant (Human) Sales by Region: 2027-2032
- 5.3 Global Fibrin Sealant (Human) Revenue by Region: 2021-2032
- 5.3.1 Global Fibrin Sealant (Human) Revenue by Region: 2021-2026
- 5.3.2 Global Fibrin Sealant (Human) Revenue by Region: 2027-2032
- 5.4 North America Fibrin Sealant (Human) Market Facts & Figures by Country
- 5.4.1 North America Fibrin Sealant (Human) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fibrin Sealant (Human) Sales by Country (2021-2032)
- 5.4.3 North America Fibrin Sealant (Human) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Fibrin Sealant (Human) Market Facts & Figures by Country
- 5.5.1 Europe Fibrin Sealant (Human) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fibrin Sealant (Human) Sales by Country (2021-2032)
- 5.5.3 Europe Fibrin Sealant (Human) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Fibrin Sealant (Human) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fibrin Sealant (Human) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fibrin Sealant (Human) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fibrin Sealant (Human) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fibrin Sealant (Human) Market Facts & Figures by Country
- 5.7.1 South America Fibrin Sealant (Human) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fibrin Sealant (Human) Sales by Country (2021-2032)
- 5.7.3 South America Fibrin Sealant (Human) Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Fibrin Sealant (Human) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fibrin Sealant (Human) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fibrin Sealant (Human) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fibrin Sealant (Human) Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Fibrin Sealant (Human) Sales by Type (2021-2032)
- 6.1.1 Global Fibrin Sealant (Human) Sales by Type (2021-2032) & (K Tons)
- 6.1.2 Global Fibrin Sealant (Human) Sales Market Share by Type (2021-2032)
- 6.2 Global Fibrin Sealant (Human) Revenue by Type (2021-2032)
- 6.2.1 Global Fibrin Sealant (Human) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fibrin Sealant (Human) Revenue Market Share by Type (2021-2032)
- 6.3 Global Fibrin Sealant (Human) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fibrin Sealant (Human) Sales by Application (2021-2032)
- 7.1.1 Global Fibrin Sealant (Human) Sales by Application (2021-2032) & (K Tons)
- 7.1.2 Global Fibrin Sealant (Human) Sales Market Share by Application (2021-2032)
- 7.2 Global Fibrin Sealant (Human) Revenue by Application (2021-2032)
- 7.2.1 Global Fibrin Sealant (Human) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fibrin Sealant (Human) Revenue Market Share by Application (2021-2032)
- 7.3 Global Fibrin Sealant (Human) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fibrin Sealant (Human) Value Chain Analysis
- 8.1.1 Fibrin Sealant (Human) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fibrin Sealant (Human) Production Mode & Process
- 8.2 Fibrin Sealant (Human) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fibrin Sealant (Human) Distributors
- 8.2.3 Fibrin Sealant (Human) Customers
9 Global Fibrin Sealant (Human) Analyzing Market Dynamics
- 9.1 Fibrin Sealant (Human) Industry Trends
- 9.2 Fibrin Sealant (Human) Industry Drivers
- 9.3 Fibrin Sealant (Human) Industry Opportunities and Challenges
- 9.4 Fibrin Sealant (Human) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst